Servier Laboratories is a privately owned French pharmaceutical company that specialises in medication for cardiological and rheumatological conditions, as well as for diabetes and clinical depression.
For more information, visit http://servier.com.au
Depression affects a person emotionally, psychologically, physically and socially, and recovery can be an arduous task. We look at one patient's journey of battling and overcoming depression.
As the primary providers of mental health care for the Australian community, it is important for GPs to provide effective strategies for managing depression and address patients' concerns. Dr Richard Smith of the Toorak Medical Clinic explores the options available, and how the TAILOR Clinical Audit can improve outcomes.
Clinical Audit: TAILOR - Target Antidepressant Initiation choice to unLock positive patient Outcomes and Response
This clinical audit aims to tailor the choice of anti-depressant medication for the initial management of a patient with depression based on maintaining therapy long term to achieve more positive patient outcomes and response with a clear focus on involving the patient in all management decisions.